Source comparison
Clinical Dosing Protocols for Erectile Function vs Tanning Applications
The dose required for erectile benefit is significantly lower than the dose used for melanogenesis. Early Phase II trials established a threshold dose of 0.016mg/kg subcutaneously for measurable erectile improvement, while tanning protocols typically use 0.025
This comparison does not assign a generated winner or score.
- The dose required for erectile benefit is significantly lower than the dose used for melanogenesis. Early Phase II trials established a threshold dose of 0.016mg/kg subcutaneously for measurable erectile improvement, while tanning protocols typically use 0.025–0.030mg/kg. For a 90kg individual, the erectile function dose translates to approximately 1.4mg per administration, while tanning protocols run 2.0–2.7mg. This difference matters because nausea. The primary limiting side effect. Is dose-dependent and occurs in 40–60% of subjects at doses above 2mg.
- Research published in the Journal of Sexual Medicine evaluated dosing frequency and found that twice-weekly administration (Monday/Thursday or Tuesday/Friday scheduling) produced sustained erectile improvement without tachyphylaxis over 12-week observation periods. Daily dosing did not improve outcomes and increased nausea rates to 65–70%. The half-life of subcutaneous MT-2 is approximately 33 hours, meaning plasma levels remain detectable for 4–5 days after a single dose.
- The Melanotan-2 formulation available through research suppliers like Real Peptides uses lyophilized powder reconstituted with bacteriostatic water at standard concentrations of 10mg per vial. For erectile function research, this translates to 0.14–0.16mL injections twice weekly for a 90kg subject when reconstituted to 10mg/mL concentration. Precision dosing requires an insulin syringe calibrated in 0.01mL increments. Volumetric errors of more than 10% meaningfully alter the nausea-to-benefit ratio.